Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TEPOTINIB Cause Therapy partial responder? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Therapy partial responder have been filed in association with TEPOTINIB (TEPMETKO). This represents 1.1% of all adverse event reports for TEPOTINIB.

7
Reports of Therapy partial responder with TEPOTINIB
1.1%
of all TEPOTINIB reports
0
Deaths
0
Hospitalizations

How Dangerous Is Therapy partial responder From TEPOTINIB?

Of the 7 reports.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TEPOTINIB. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does TEPOTINIB Cause?

Death (117) Oedema peripheral (82) Diarrhoea (57) Renal impairment (57) Oedema (56) Fatigue (53) Disease progression (50) Nausea (43) Off label use (42) Peripheral swelling (32)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which TEPOTINIB Alternatives Have Lower Therapy partial responder Risk?

TEPOTINIB vs TEPROTUMUMAB TEPOTINIB vs TEPROTUMUMAB-TRBW TEPOTINIB vs TERAZOSIN TEPOTINIB vs TERAZOSIN\TERAZOSIN TEPOTINIB vs TERBINAFINE

Related Pages

TEPOTINIB Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder TEPOTINIB Demographics